These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 18562572)
41. [The controversial Burkholderia cepacia complex, a group of plant growth promoting species and plant, animals and human pathogens]. Rojas-Rojas FU; López-Sánchez D; Meza-Radilla G; Méndez-Canarios A; Ibarra JA; Estrada-de Los Santos P Rev Argent Microbiol; 2019; 51(1):84-92. PubMed ID: 29691107 [TBL] [Abstract][Full Text] [Related]
42. Iron acquisition mechanisms of the Burkholderia cepacia complex. Thomas MS Biometals; 2007 Jun; 20(3-4):431-52. PubMed ID: 17295049 [TBL] [Abstract][Full Text] [Related]
43. Cystic fibrosis infections: treatment strategies and prospects. George AM; Jones PM; Middleton PG FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113 [TBL] [Abstract][Full Text] [Related]
44. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Caraher E; Reynolds G; Murphy P; McClean S; Callaghan M Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):213-6. PubMed ID: 17265071 [TBL] [Abstract][Full Text] [Related]
45. Macromolecular properties of cepacian in water and in dimethylsulfoxide. Herasimenka Y; Cescutti P; Sampaio Noguera CE; Ruggiero JR; Urbani R; Impallomeni G; Zanetti F; Campidelli S; Prato M; Rizzo R Carbohydr Res; 2008 Jan; 343(1):81-9. PubMed ID: 18028888 [TBL] [Abstract][Full Text] [Related]
46. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. Shaw D; Poxton IR; Govan JR FEMS Immunol Med Microbiol; 1995 Apr; 11(2):99-106. PubMed ID: 7640678 [TBL] [Abstract][Full Text] [Related]
47. The Burkholderia cepacia complex and cytokine induction: an inflammatory tale. Govan JR Pediatr Res; 2003 Sep; 54(3):294-6. PubMed ID: 12761357 [No Abstract] [Full Text] [Related]
48. RecA gene sequence and Multilocus Sequence Typing for species-level resolution of Burkholderia cepacia complex isolates. Cesarini S; Bevivino A; Tabacchioni S; Chiarini L; Dalmastri C Lett Appl Microbiol; 2009 Nov; 49(5):580-8. PubMed ID: 19732325 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of indeterminate genetic species of Burkholderia cepacia complex in a cystic fibrosis center in Argentina. Jordá-Vargas L; Degrossi J; Castañeda NC; D'Aquino M; Valvano MA; Procopio A; Galanternik L; Centrón D J Clin Microbiol; 2008 Mar; 46(3):1151-2. PubMed ID: 18199792 [No Abstract] [Full Text] [Related]
50. Clinical follow-up of 122 Italian cystic fibrosis patients with B. cepacia complex colonisation. Taccetti G; Costantini D; Furnari ML J Cyst Fibros; 2005 May; 4(2):145-6; author reply 147. PubMed ID: 15978538 [No Abstract] [Full Text] [Related]
51. Disinfection of Burkholderia cepacia complex from non-touch taps in a neonatal nursery. Kotsanas D; Brett J; Kidd TJ; Stuart RL; Korman TM J Perinat Med; 2008; 36(3):235-9. PubMed ID: 18576933 [TBL] [Abstract][Full Text] [Related]
52. Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis. Marioni G; Rinaldi R; Staffieri C; Ottaviano G; Marchese-Ragona R; Giacomelli L; Ferraro SM; Staffieri A Eur J Clin Microbiol Infect Dis; 2007 Jan; 26(1):73-5. PubMed ID: 17180349 [No Abstract] [Full Text] [Related]
53. Evolving serodiagnostics by rationally designed peptide arrays: the Burkholderia paradigm in Cystic Fibrosis. Peri C; Gori A; Gagni P; Sola L; Girelli D; Sottotetti S; Cariani L; Chiari M; Cretich M; Colombo G Sci Rep; 2016 Sep; 6():32873. PubMed ID: 27615705 [TBL] [Abstract][Full Text] [Related]
54. A type IV secretion system contributes to intracellular survival and replication of Burkholderia cenocepacia. Sajjan SU; Carmody LA; Gonzalez CF; LiPuma JJ Infect Immun; 2008 Dec; 76(12):5447-55. PubMed ID: 18824538 [TBL] [Abstract][Full Text] [Related]
55. Identification of lysine positive non-fermenting gram negative bacilli (Stenotrophomonas maltophilia and Burkholderia cepacia complex). Gautam V; Ray P; Vandamme P; Chatterjee SS; Das A; Sharma K; Rana S; Garg RK; Madhup SK; Mahajan M; Sharma M Indian J Med Microbiol; 2009; 27(2):128-33. PubMed ID: 19384035 [TBL] [Abstract][Full Text] [Related]
56. Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide. Silipo A; Molinaro A; Cescutti P; Bedini E; Rizzo R; Parrilli M; Lanzetta R Glycobiology; 2005 May; 15(5):561-70. PubMed ID: 15610978 [TBL] [Abstract][Full Text] [Related]
57. Temperate bacteriophages DK4 and BcepMu from Burkholderia cenocepacia J2315 are identical. Langley RJ; Kenna D; Bartholdson J; Campopiano DJ; Govan JR FEMS Immunol Med Microbiol; 2005 Aug; 45(2):349-50. PubMed ID: 16009540 [No Abstract] [Full Text] [Related]
58. Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts. Uehlinger S; Schwager S; Bernier SP; Riedel K; Nguyen DT; Sokol PA; Eberl L Infect Immun; 2009 Sep; 77(9):4102-10. PubMed ID: 19528212 [TBL] [Abstract][Full Text] [Related]
59. A rapid and efficient method for directed screening of lipase-producing Burkholderia cepacia complex strains with organic solvent tolerance from rhizosphere. Shu Z; Lin R; Jiang H; Zhang Y; Wang M; Huang J J Biosci Bioeng; 2009 Jun; 107(6):658-61. PubMed ID: 19447345 [TBL] [Abstract][Full Text] [Related]
60. Crystal structures of the Kumar N; Su CC; Chou TH; Radhakrishnan A; Delmar JA; Rajashankar KR; Yu EW Proc Natl Acad Sci U S A; 2017 Jun; 114(25):6557-6562. PubMed ID: 28584102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]